logo

For the Inventor, By the Inventor

Pasadena, CA, United States of America

Marlys Hammond

This inventor holds 13 USPTO granted patents. Top assignees: Eli Lilly and Company, Agouron Pharmaceuticals, Inc.. Active years: 1995-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marlys Hammond. Retrieved from https://idiyas.com/inventor/marlys-hammond-zg6hv96d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13

% Patents Active = 84.6

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 120(Granted Patents)


Location History:

  • Indianapolis, IN (US) (1996 - 1998)
  • Pasadena, CA (US) (1995 - 2004)

Company Filing History:

goldMedal7 out of 4,520 
 
Eli Lilly and Company
 patents
silverMedal6 out of 174 
 
Agouron Pharmaceuticals, Inc.
 patents

Years Active: 1995-2004

Loading Chart...
13 patents (USPTO):Explore Patents
1. 6693199 - Method of making HIV protease inhibitors (2004-02-17),
2. 6525215 - HIV protease inhibitors (2003-02-25),
3. 6162812 - Pharmaceutical compositions containing HIV protease inhibitors and (2000-12-19),
4. 5834467 - HIV protease inhibitors (1998-11-10),
5. 5827891 - HIV protease inhibtors (1998-10-27),
6. 5821331 - Anti-picornaviral agents (1998-10-13),
7. 5719287 - Intermediates for inhibitors of HIV protease and method of preparation (1998-02-17),
8. 5514802 - Intermediates for preparing HIV protease inhibitors (1996-05-07),
9. 5514778 - Anti-picornaviral agents (1996-05-07),
10. 5508407 - Retroviral protease inhibitors (1996-04-16),
11. 5484926 - HIV protease inhibitors (1996-01-16),
12. 5475136 - Inhibitors of HIV protease useful for the treatment of AIDS (1995-12-12),
13. 5434265 - Inhibitors of HIV protease (1995-07-18),

Title: Marlys Hammond: Innovator in HIV Protease Inhibitors

Introduction

Marlys Hammond is a distinguished inventor based in Pasadena, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of HIV protease inhibitors. With a total of 13 patents to her name, her work has had a profound impact on medical research and treatment options for HIV.

Latest Patents

Among her latest patents, Hammond has developed a method of making HIV protease inhibitors. This includes compounds that are useful as intermediates in the preparation of these inhibitors. The compounds she has worked on have a specific general formula that contributes to their effectiveness in combating HIV.

Career Highlights

Throughout her career, Marlys Hammond has been associated with prominent companies in the pharmaceutical industry. She has worked with Eli Lilly and Company and Agouron Pharmaceuticals, Inc., where she has applied her expertise to advance medical research and innovation.

Collaborations

Marlys has collaborated with notable professionals in her field, including Stephen W. Kaldor and James E. Fritz. These partnerships have further enhanced her research and development efforts in the pharmaceutical sector.

Conclusion

Marlys Hammond's contributions to the field of HIV protease inhibitors exemplify her dedication to innovation and medical advancement. Her work continues to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…